Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 infusion duration and gastric emptying study in healthy volunteers
ACTRN12612001035819Phase 2Recruiting
- Sponsor
- Mahesh Umapathysivam
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Glucagon-like peptide 1 in hyperglycemia, diabetes mellitus (DM) and Stress Hyperglycemia (SH) (4 arms), sponsored by Mahesh Umapathysivam. Primary endpoint: Scintigraphic measurement of gastric emptying. Started Jun 2012; status: recruiting.
02
Drugs
Glucagon-like peptide 1
03
Conditions
hyperglycemiadiabetes mellitus (DM)Stress Hyperglycemia (SH)
Beyond the preview
Go deeper on ACTRN12612001035819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001035819.